Revvity Inc. (RVTY) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Revvity, Inc. provides health sciences solutions, technologies, and services.
Total Assets Chart for Revvity Inc.
Revvity Inc. (RVTY) total assets for FY2025 were USD 12.2B, a -1.8% change from FY2024. Revvity Inc.'s total assets grew from USD 429.8M in 1985 to USD 12.2B in 2025 (2731.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 8.9%, 10-year CAGR of 11.3%, 20-year CAGR of 7.8%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $12.74B
- Implied Share Price
- $114.24
- Enterprise Value
- $14.92B
- Revenue (TTM)
- $2.91B
- EBITDA
- $866.87M
- Profit Margin
- 8.16%
- Trailing P/E
- 55.19
- Forward P/E
- 21.28
- Price/Book (MRQ)
- 1.73
- Price/Sales (TTM)
- 4.38
- EV/EBITDA
- 19.30
- EV/Revenue
- 5.14
- Dividend Yield
- 0.12%
- Book Value
- $64.76
- Free Cash Flow (FY2025)
- $508.25M
- Free Cash Flow Yield
- 3.99%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.